Form 4 for NXL Nexalin Technology, Inc.
Accepted 2024-06-21 00:00:00 ET · period of report 2024-06-18 · accession 0001829126-24-004353 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-21 | 2024-06-18 | NXL | Owens David | Chief Medical Off, Dir | P - Purchase | $0.71 | +1,619 | 145.8K | +1% | +$1,149 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-06-18 | P | A | 1,619 | $0.71 | 145,793 | D | — | — |